Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

3(30.0%)

N/A

3(30.0%)

Early Phase 1

2(20.0%)

Phase 1

1(10.0%)

Phase 4

1(10.0%)

10Total

Phase 3(3)

N/A(3)

Early Phase 1(2)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06958146Phase 4Not Yet Recruiting

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

Role: lead

NCT06522581Phase 1Recruiting

Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy

Role: lead

NCT05831501Not ApplicableCompleted

Postoperative Analgesic Efficacy of Trans Abdominis Plane Block

Role: lead

NCT05022160Early Phase 1Unknown

Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block

Role: lead

NCT04809532Not ApplicableUnknown

Trans Abdominis Plane (TAP) Block in Patients With Cesarean Section

Role: lead

NCT04728308Early Phase 1Unknown

Bupivacaine Infiltration and Postoperative Pain

Role: lead

NCT04721054Not ApplicableCompleted

Thoracic Epidural Versus General Anesthesia for Laparoscopic Cholecystectomy

Role: lead

NCT03702946Phase 3Completed

Oxytocin Infusion and Abdominal Myomectomy

Role: lead

NCT03208894Phase 3Completed

Role of Salbutamol and Furosemide in TTN

Role: lead

NCT03181646Phase 3Unknown

Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy

Role: lead

All 10 trials loaded